Efficacy and Safety of Metoprolol Tartrate Tablets Combined With Chinese Traditional Medicine on Premature Ventricular Complex.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 584 participants.

Also called NCT05008250

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 584 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05008250
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05008250. Randomized; double masking; primary purpose treatment. Start 2014-01 (actual); primary completion 2015-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Metoprolol Tartrate Tablets Combined With Chinese Traditional Medicine on Premature Ventricular Complex.
Condition
Premature Ventricular Contraction
Intervention (Drug)
Tongmai Yangxin Pill (TMYXP)
Intervention (Drug)
metoprolol tartrate
Intervention (Drug)
placebo
Lead sponsor
Xuanwu Hospital, Beijing (class: other)
Collaborator
Tianjin Lerentang factory (class: not stated)

Record details

Record id
cardio:ct-nct05008250
Content hash
de0498800c6991df5b4ccd48a8634328218426837446bb20c5f4ea0add26be14